Product image of Celdoxome Pegylated Liposomal (Doxorubicin Hydrochloride) supplied by GNH India

Celdoxome Pegylated Liposomal

Active Ingredient:
Doxorubicin Hydrochloride
Origin:
EU

Celdoxome Pegylated Liposomal (Doxorubicin Hydrochloride)

Celdoxome Pegylated Liposomal is a liposomal formulation of doxorubicin hydrochloride, used for targeted chemotherapy. It is designed for intravenous administration and is manufactured by Baxter Holding B.V. in the EU.

Manufacturer / TM Owner

Baxter Holding B.V.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Celdoxome Pegylated Liposomal is primarily used in chemotherapy to treat various types of cancer. The liposomal formulation aims to deliver doxorubicin hydrochloride directly to cancer cells, potentially reducing side effects compared to conventional doxorubicin. This medication is often used in the treatment of cancers such as ovarian cancer, multiple myeloma, and Kaposi's sarcoma. Patients should consult their healthcare provider to determine if this medication is suitable for their specific condition.

Side Effects

  • Common effects of Celdoxome Pegylated Liposomal may include fatigue, nausea, and hair loss. Some patients may experience more severe side effects such as myelosuppression, which can lead to a decreased ability to fight infections. It is important to monitor for signs of infection, bleeding, or unusual bruising. Patients should report any severe or persistent side effects to their healthcare provider immediately.

Precautions & Warnings

  • Celdoxome Pegylated Liposomal should be handled with care and administered by a healthcare professional experienced in chemotherapy. It is important to follow all safety protocols when handling this medication to avoid accidental exposure. Patients should be monitored regularly for signs of side effects and potential complications. Pregnant women and individuals with pre-existing heart conditions should exercise caution and consult their healthcare provider before use.

Avoid Interactions

  • Celdoxome Pegylated Liposomal may interact with other medications, including those that affect the liver or bone marrow. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol and certain supplements may also interact with this medication. Always consult your healthcare provider before starting or stopping any medications while using Celdoxome Pegylated Liposomal.

Frequently Asked Questions

Celdoxome Pegylated Liposomal is used in chemotherapy to treat various types of cancer, including ovarian cancer, multiple myeloma, and Kaposi's sarcoma.

Celdoxome Pegylated Liposomal is administered intravenously by a healthcare professional.

Common side effects may include fatigue, nausea, hair loss, and myelosuppression.

Celdoxome Pegylated Liposomal is manufactured by Baxter Holding B.V. in the EU.

Precautions include handling with care, regular monitoring for side effects, and consulting a healthcare provider before use, especially for pregnant women and individuals with heart conditions.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Doxorubicin Hydrochloride

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT